Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mutation | 22 | 2024 | 3968 | 1.490 |
Why?
|
Molecular Dynamics Simulation | 10 | 2014 | 245 | 1.340 |
Why?
|
Proteins | 5 | 2024 | 777 | 1.320 |
Why?
|
Adenocarcinoma | 3 | 2023 | 1169 | 1.200 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2022 | 381 | 1.170 |
Why?
|
Esophageal Neoplasms | 3 | 2023 | 321 | 1.120 |
Why?
|
Receptor, Notch1 | 5 | 2023 | 85 | 1.110 |
Why?
|
Cell Membrane | 10 | 2014 | 666 | 1.060 |
Why?
|
KCNQ Potassium Channels | 1 | 2023 | 7 | 0.950 |
Why?
|
Clonal Evolution | 1 | 2023 | 15 | 0.930 |
Why?
|
Signal Transduction | 8 | 2020 | 3241 | 0.920 |
Why?
|
Models, Molecular | 9 | 2020 | 1286 | 0.920 |
Why?
|
Carcinogenesis | 4 | 2023 | 195 | 0.910 |
Why?
|
Epithelium | 4 | 2023 | 319 | 0.900 |
Why?
|
Caenorhabditis elegans | 2 | 2015 | 223 | 0.890 |
Why?
|
Metabolomics | 1 | 2022 | 68 | 0.860 |
Why?
|
Skin Neoplasms | 3 | 2023 | 546 | 0.860 |
Why?
|
Clone Cells | 6 | 2022 | 213 | 0.840 |
Why?
|
Neoplasms | 6 | 2022 | 2898 | 0.810 |
Why?
|
Leiomyomatosis | 1 | 2021 | 12 | 0.790 |
Why?
|
DNA Repair | 2 | 2021 | 356 | 0.780 |
Why?
|
Membrane Proteins | 9 | 2022 | 1196 | 0.770 |
Why?
|
Myeloproliferative Disorders | 1 | 2022 | 110 | 0.760 |
Why?
|
Epithelial Cells | 3 | 2021 | 669 | 0.760 |
Why?
|
Stem Cells | 3 | 2020 | 351 | 0.740 |
Why?
|
Germ Cells | 2 | 2020 | 126 | 0.680 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 329 | 0.680 |
Why?
|
DNA Damage | 1 | 2019 | 366 | 0.620 |
Why?
|
Models, Biological | 7 | 2020 | 1749 | 0.600 |
Why?
|
Uterine Neoplasms | 1 | 2021 | 227 | 0.600 |
Why?
|
Software | 2 | 2020 | 654 | 0.570 |
Why?
|
Models, Genetic | 2 | 2019 | 926 | 0.560 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2022 | 763 | 0.560 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 621 | 0.530 |
Why?
|
Immediate-Early Proteins | 3 | 2013 | 164 | 0.520 |
Why?
|
Selection, Genetic | 1 | 2019 | 502 | 0.520 |
Why?
|
Epidermis | 3 | 2020 | 100 | 0.510 |
Why?
|
Organogenesis | 1 | 2014 | 41 | 0.490 |
Why?
|
Homeostasis | 2 | 2018 | 409 | 0.490 |
Why?
|
Peptides | 3 | 2012 | 639 | 0.460 |
Why?
|
Receptors, Cell Surface | 2 | 2011 | 286 | 0.460 |
Why?
|
Bacterial Proteins | 4 | 2013 | 864 | 0.450 |
Why?
|
Lopinavir | 1 | 2012 | 5 | 0.440 |
Why?
|
HIV Protease | 1 | 2012 | 10 | 0.440 |
Why?
|
HIV Protease Inhibitors | 1 | 2012 | 21 | 0.440 |
Why?
|
Ritonavir | 1 | 2012 | 12 | 0.430 |
Why?
|
Membrane Microdomains | 1 | 2012 | 54 | 0.430 |
Why?
|
Protein Conformation | 5 | 2012 | 881 | 0.430 |
Why?
|
Catalytic Domain | 1 | 2012 | 156 | 0.420 |
Why?
|
Computer Simulation | 9 | 2024 | 1078 | 0.420 |
Why?
|
Protein Structure, Secondary | 10 | 2013 | 330 | 0.410 |
Why?
|
Water | 2 | 2012 | 277 | 0.410 |
Why?
|
Esophagus | 3 | 2022 | 102 | 0.410 |
Why?
|
Estrogen Receptor alpha | 1 | 2012 | 144 | 0.400 |
Why?
|
Genotype | 2 | 2017 | 1851 | 0.380 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2023 | 1076 | 0.380 |
Why?
|
Lipid Bilayers | 7 | 2012 | 134 | 0.370 |
Why?
|
Escherichia coli Proteins | 1 | 2011 | 179 | 0.370 |
Why?
|
Humans | 27 | 2024 | 86644 | 0.340 |
Why?
|
Genomics | 2 | 2024 | 720 | 0.280 |
Why?
|
Protein Binding | 6 | 2024 | 1456 | 0.280 |
Why?
|
Animals | 19 | 2023 | 26582 | 0.280 |
Why?
|
Cell Proliferation | 4 | 2021 | 1578 | 0.270 |
Why?
|
Mice | 12 | 2023 | 11352 | 0.250 |
Why?
|
Macrophages | 3 | 2024 | 554 | 0.250 |
Why?
|
Breast Neoplasms | 2 | 2021 | 2903 | 0.240 |
Why?
|
Thermodynamics | 4 | 2012 | 309 | 0.240 |
Why?
|
KCNQ3 Potassium Channel | 1 | 2023 | 2 | 0.240 |
Why?
|
KCNQ2 Potassium Channel | 1 | 2023 | 4 | 0.240 |
Why?
|
Smad4 Protein | 1 | 2023 | 23 | 0.240 |
Why?
|
Cell Cycle | 3 | 2020 | 502 | 0.230 |
Why?
|
Protein Stability | 2 | 2021 | 99 | 0.230 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 52 | 0.220 |
Why?
|
Arthritis, Rheumatoid | 1 | 2024 | 166 | 0.210 |
Why?
|
Metabolic Networks and Pathways | 1 | 2022 | 79 | 0.210 |
Why?
|
Mass Spectrometry | 1 | 2022 | 188 | 0.210 |
Why?
|
Lactic Acid | 1 | 2022 | 90 | 0.210 |
Why?
|
Amino Acid Sequence | 8 | 2013 | 2062 | 0.210 |
Why?
|
Lymphatic Metastasis | 1 | 2023 | 486 | 0.200 |
Why?
|
Spike Glycoprotein, Coronavirus | 1 | 2021 | 40 | 0.200 |
Why?
|
Fumarate Hydratase | 1 | 2021 | 6 | 0.200 |
Why?
|
Arginine | 2 | 2012 | 136 | 0.200 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2021 | 100 | 0.190 |
Why?
|
Molecular Sequence Data | 8 | 2013 | 3030 | 0.190 |
Why?
|
Cell Survival | 2 | 2021 | 969 | 0.190 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2011 | 57 | 0.190 |
Why?
|
Fibroblasts | 3 | 2022 | 729 | 0.190 |
Why?
|
Carcinoma, Basal Cell | 1 | 2020 | 54 | 0.190 |
Why?
|
BRCA2 Protein | 1 | 2021 | 158 | 0.180 |
Why?
|
Dictyostelium | 1 | 2020 | 43 | 0.180 |
Why?
|
Sequence Analysis, DNA | 1 | 2023 | 853 | 0.180 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 56 | 0.180 |
Why?
|
Eyelids | 1 | 2019 | 23 | 0.180 |
Why?
|
Mutagenesis | 1 | 2019 | 199 | 0.170 |
Why?
|
Cyclic AMP | 1 | 2020 | 273 | 0.170 |
Why?
|
Stromal Cells | 2 | 2018 | 143 | 0.170 |
Why?
|
Osmoregulation | 1 | 2018 | 2 | 0.170 |
Why?
|
Homeodomain Proteins | 1 | 2022 | 536 | 0.170 |
Why?
|
Binding Sites | 3 | 2024 | 1098 | 0.160 |
Why?
|
Systems Biology | 1 | 2018 | 42 | 0.160 |
Why?
|
Female | 12 | 2021 | 44533 | 0.160 |
Why?
|
Cell Line | 1 | 2022 | 2468 | 0.160 |
Why?
|
Cell Lineage | 2 | 2020 | 273 | 0.160 |
Why?
|
Time Factors | 4 | 2021 | 5210 | 0.160 |
Why?
|
Computational Biology | 3 | 2018 | 528 | 0.150 |
Why?
|
Lymph Nodes | 2 | 2022 | 533 | 0.150 |
Why?
|
Simvastatin | 1 | 2017 | 106 | 0.150 |
Why?
|
Diet, High-Fat | 1 | 2017 | 114 | 0.140 |
Why?
|
Protein Multimerization | 3 | 2013 | 173 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2017 | 592 | 0.130 |
Why?
|
Gonads | 1 | 2015 | 19 | 0.130 |
Why?
|
Herpesvirus 8, Human | 1 | 2015 | 11 | 0.130 |
Why?
|
Sarcoma, Kaposi | 1 | 2015 | 19 | 0.130 |
Why?
|
I-kappa B Kinase | 1 | 2015 | 37 | 0.130 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 3092 | 0.130 |
Why?
|
Adipose Tissue | 1 | 2017 | 240 | 0.130 |
Why?
|
Genome, Helminth | 1 | 2014 | 5 | 0.130 |
Why?
|
Vulva | 1 | 2014 | 23 | 0.130 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 744 | 0.130 |
Why?
|
Potassium Channels, Inwardly Rectifying | 2 | 2005 | 119 | 0.120 |
Why?
|
Video Recording | 1 | 2015 | 190 | 0.120 |
Why?
|
Dexamethasone | 2 | 2013 | 326 | 0.120 |
Why?
|
Apoptosis | 3 | 2015 | 1683 | 0.120 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 23 | 0.120 |
Why?
|
Receptors, Notch | 1 | 2014 | 120 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 427 | 0.120 |
Why?
|
Hormone Antagonists | 1 | 2013 | 20 | 0.120 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2013 | 29 | 0.120 |
Why?
|
Peptide Fragments | 2 | 2012 | 460 | 0.120 |
Why?
|
Mifepristone | 1 | 2013 | 33 | 0.120 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 173 | 0.120 |
Why?
|
Viral Proteins | 1 | 2015 | 300 | 0.120 |
Why?
|
Movement | 2 | 2012 | 299 | 0.120 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2014 | 109 | 0.110 |
Why?
|
Databases, Protein | 2 | 2010 | 52 | 0.110 |
Why?
|
Alphaproteobacteria | 1 | 2013 | 5 | 0.110 |
Why?
|
Simian Immunodeficiency Virus | 1 | 2012 | 17 | 0.110 |
Why?
|
Viral Fusion Proteins | 1 | 2012 | 10 | 0.110 |
Why?
|
Mice, Transgenic | 3 | 2022 | 1540 | 0.110 |
Why?
|
Vesicle-Associated Membrane Protein 2 | 1 | 2012 | 2 | 0.110 |
Why?
|
Membrane Fluidity | 1 | 2012 | 8 | 0.110 |
Why?
|
Voltage-Gated Sodium Channels | 1 | 2013 | 17 | 0.110 |
Why?
|
Calcium Signaling | 1 | 2013 | 129 | 0.110 |
Why?
|
Furans | 1 | 2012 | 16 | 0.110 |
Why?
|
Mechanistic Target of Rapamycin Complex 2 | 1 | 2012 | 11 | 0.110 |
Why?
|
Mechanical Phenomena | 1 | 2012 | 13 | 0.110 |
Why?
|
Enzyme Activators | 1 | 2012 | 14 | 0.110 |
Why?
|
Phosphatidylcholines | 1 | 2012 | 48 | 0.110 |
Why?
|
Thapsigargin | 1 | 2012 | 55 | 0.110 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 1 | 2012 | 29 | 0.110 |
Why?
|
Drug Resistance, Viral | 1 | 2012 | 51 | 0.110 |
Why?
|
Receptors, Glucocorticoid | 1 | 2013 | 120 | 0.110 |
Why?
|
Cell Differentiation | 2 | 2016 | 1458 | 0.110 |
Why?
|
MCF-7 Cells | 1 | 2012 | 106 | 0.110 |
Why?
|
Escherichia coli | 2 | 2013 | 597 | 0.100 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2011 | 5 | 0.100 |
Why?
|
Protein Structure, Tertiary | 5 | 2014 | 736 | 0.100 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 95 | 0.100 |
Why?
|
Integrin beta3 | 1 | 2011 | 30 | 0.100 |
Why?
|
Models, Chemical | 1 | 2012 | 178 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2012 | 150 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 262 | 0.100 |
Why?
|
ErbB Receptors | 1 | 2014 | 485 | 0.100 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2013 | 137 | 0.100 |
Why?
|
Dengue | 1 | 2011 | 43 | 0.100 |
Why?
|
Dengue Virus | 1 | 2011 | 41 | 0.100 |
Why?
|
Sirolimus | 1 | 2012 | 169 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 182 | 0.100 |
Why?
|
Lectins, C-Type | 1 | 2011 | 85 | 0.100 |
Why?
|
Enzyme Activation | 1 | 2012 | 692 | 0.100 |
Why?
|
Algorithms | 3 | 2015 | 1830 | 0.100 |
Why?
|
Up-Regulation | 1 | 2013 | 712 | 0.100 |
Why?
|
Database Management Systems | 1 | 2010 | 41 | 0.100 |
Why?
|
Obesity | 1 | 2017 | 963 | 0.100 |
Why?
|
Internet | 2 | 2010 | 312 | 0.090 |
Why?
|
Ion Channel Gating | 3 | 2013 | 324 | 0.090 |
Why?
|
Pyridines | 1 | 2012 | 310 | 0.090 |
Why?
|
Ultraviolet Rays | 2 | 2023 | 193 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2020 | 2705 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 371 | 0.090 |
Why?
|
Mitochondria | 1 | 2013 | 535 | 0.090 |
Why?
|
Phosphorylation | 1 | 2012 | 1106 | 0.090 |
Why?
|
Pyrimidines | 1 | 2012 | 370 | 0.090 |
Why?
|
Ligands | 2 | 2007 | 433 | 0.080 |
Why?
|
Islets of Langerhans | 1 | 2012 | 544 | 0.080 |
Why?
|
Calcium | 1 | 2013 | 1156 | 0.080 |
Why?
|
Cell Death | 2 | 2021 | 256 | 0.080 |
Why?
|
Insulin-Secreting Cells | 1 | 2012 | 397 | 0.080 |
Why?
|
Periplasmic Binding Proteins | 1 | 2007 | 25 | 0.080 |
Why?
|
Insulin | 1 | 2012 | 1160 | 0.070 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 87 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 2 | 2024 | 339 | 0.070 |
Why?
|
Archaeal Proteins | 1 | 2006 | 18 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2012 | 318 | 0.070 |
Why?
|
Protein Folding | 1 | 2007 | 282 | 0.070 |
Why?
|
Ion Channels | 2 | 2022 | 246 | 0.060 |
Why?
|
HEK293 Cells | 2 | 2021 | 615 | 0.060 |
Why?
|
Cell Line, Tumor | 3 | 2017 | 2426 | 0.060 |
Why?
|
Lung Neoplasms | 1 | 2017 | 2262 | 0.060 |
Why?
|
Crystallography, X-Ray | 3 | 2013 | 485 | 0.060 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 296 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2007 | 673 | 0.060 |
Why?
|
Caspase 3 | 2 | 2013 | 159 | 0.060 |
Why?
|
Chromosomal Instability | 1 | 2022 | 19 | 0.060 |
Why?
|
Static Electricity | 2 | 2013 | 89 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 2232 | 0.060 |
Why?
|
Keratinocytes | 1 | 2023 | 143 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 1197 | 0.050 |
Why?
|
Electron Spin Resonance Spectroscopy | 2 | 2015 | 306 | 0.050 |
Why?
|
Homologous Recombination | 1 | 2021 | 51 | 0.050 |
Why?
|
Forearm | 1 | 2020 | 32 | 0.050 |
Why?
|
Male | 5 | 2021 | 40966 | 0.050 |
Why?
|
Diethylnitrosamine | 1 | 2020 | 7 | 0.050 |
Why?
|
Receptor, Notch2 | 1 | 2020 | 6 | 0.050 |
Why?
|
ADAM10 Protein | 1 | 2020 | 7 | 0.050 |
Why?
|
Thorax | 1 | 2020 | 75 | 0.050 |
Why?
|
Leg | 1 | 2020 | 137 | 0.050 |
Why?
|
Dimerization | 2 | 2014 | 143 | 0.050 |
Why?
|
HeLa Cells | 1 | 2021 | 498 | 0.050 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2020 | 93 | 0.040 |
Why?
|
Cadherins | 1 | 2020 | 151 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2021 | 276 | 0.040 |
Why?
|
Oscillometry | 1 | 2018 | 25 | 0.040 |
Why?
|
Cell Division | 1 | 2020 | 696 | 0.040 |
Why?
|
Inflammation | 1 | 2024 | 920 | 0.040 |
Why?
|
Embryo, Mammalian | 1 | 2018 | 207 | 0.040 |
Why?
|
Biological Transport | 1 | 2018 | 396 | 0.040 |
Why?
|
Cell Cycle Checkpoints | 1 | 2017 | 63 | 0.040 |
Why?
|
Chemokine CCL21 | 1 | 2016 | 16 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 456 | 0.040 |
Why?
|
Interleukin-7 | 1 | 2016 | 41 | 0.040 |
Why?
|
Imidazoles | 1 | 2017 | 162 | 0.040 |
Why?
|
Cellular Reprogramming | 1 | 2016 | 37 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 124 | 0.030 |
Why?
|
Middle Aged | 3 | 2023 | 25028 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2016 | 103 | 0.030 |
Why?
|
Piperazines | 1 | 2017 | 272 | 0.030 |
Why?
|
Principal Component Analysis | 2 | 2006 | 155 | 0.030 |
Why?
|
Interleukin-3 | 1 | 2015 | 36 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2015 | 116 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2015 | 52 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 266 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 77 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2016 | 232 | 0.030 |
Why?
|
Imatinib Mesylate | 1 | 2015 | 126 | 0.030 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2015 | 107 | 0.030 |
Why?
|
ras Proteins | 1 | 2015 | 128 | 0.030 |
Why?
|
Caspase 7 | 1 | 2013 | 15 | 0.030 |
Why?
|
Mitochondrial Membranes | 1 | 2013 | 14 | 0.030 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2013 | 17 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2013 | 88 | 0.030 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2013 | 46 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2015 | 256 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 378 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2018 | 2818 | 0.030 |
Why?
|
Necrosis | 1 | 2013 | 204 | 0.030 |
Why?
|
Mice, SCID | 1 | 2013 | 252 | 0.030 |
Why?
|
Tumor Microenvironment | 1 | 2016 | 418 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 391 | 0.030 |
Why?
|
Pancreatic Hormones | 1 | 2012 | 15 | 0.030 |
Why?
|
Cell Movement | 1 | 2016 | 758 | 0.030 |
Why?
|
Porosity | 1 | 2012 | 60 | 0.030 |
Why?
|
Membrane Fusion | 1 | 2012 | 37 | 0.030 |
Why?
|
Pancreas, Exocrine | 1 | 2012 | 18 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2012 | 78 | 0.030 |
Why?
|
Cytokines | 1 | 2016 | 776 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 363 | 0.030 |
Why?
|
Autopsy | 1 | 2012 | 116 | 0.030 |
Why?
|
Cell Count | 1 | 2012 | 195 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 1056 | 0.030 |
Why?
|
Phenotype | 1 | 2018 | 2378 | 0.030 |
Why?
|
Transcriptome | 1 | 2016 | 580 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 316 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2013 | 384 | 0.030 |
Why?
|
Paclitaxel | 1 | 2013 | 460 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 276 | 0.030 |
Why?
|
Temperature | 1 | 2012 | 396 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2011 | 99 | 0.020 |
Why?
|
Biomechanical Phenomena | 1 | 2012 | 457 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2013 | 1014 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 93 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2011 | 408 | 0.020 |
Why?
|
Circular Dichroism | 1 | 2010 | 117 | 0.020 |
Why?
|
Rotation | 1 | 2010 | 89 | 0.020 |
Why?
|
Infant, Premature | 1 | 2012 | 290 | 0.020 |
Why?
|
Aged | 2 | 2020 | 18415 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2010 | 185 | 0.020 |
Why?
|
Mammals | 1 | 2011 | 227 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 302 | 0.020 |
Why?
|
Gene Expression | 1 | 2013 | 1284 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 2010 | 250 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 339 | 0.020 |
Why?
|
Adult | 2 | 2020 | 25648 | 0.020 |
Why?
|
Methanococcus | 1 | 2006 | 5 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 1313 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2012 | 2380 | 0.020 |
Why?
|
Rats | 1 | 2012 | 3990 | 0.020 |
Why?
|
Biomarkers | 1 | 2012 | 1718 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 2360 | 0.020 |
Why?
|
Infant | 1 | 2012 | 3047 | 0.020 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2005 | 8 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 3612 | 0.020 |
Why?
|
Anisotropy | 1 | 2005 | 62 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2005 | 96 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 2005 | 177 | 0.020 |
Why?
|
Biophysics | 1 | 2005 | 152 | 0.020 |
Why?
|
Computer Graphics | 1 | 2004 | 100 | 0.020 |
Why?
|
Phosphates | 1 | 2005 | 160 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2005 | 416 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 2005 | 129 | 0.020 |
Why?
|
Kinetics | 1 | 2006 | 1513 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2005 | 314 | 0.010 |
Why?
|
Neurons | 1 | 2012 | 1546 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 2438 | 0.010 |
Why?
|
Potassium Channels | 1 | 2005 | 340 | 0.010 |
Why?
|
Child | 1 | 2012 | 6927 | 0.010 |
Why?
|
Young Adult | 1 | 2012 | 5976 | 0.010 |
Why?
|
Adolescent | 1 | 2012 | 8981 | 0.010 |
Why?
|